Erschienen in:
29.09.2020 | COVID-19 | Letter to the Editor
Zur Zeit gratis
COVID-19 in decompensated cirrhosis
verfasst von:
Mohamed Rela, Vaibhav Patil, Gomathy Narasimhan, Dinesh Jothimani
Erschienen in:
Hepatology International
|
Ausgabe 6/2020
Einloggen, um Zugang zu erhalten
Excerpt
COVID-19 is associated with higher mortality in patients pre-existing comorbidities. There has been several reports recently describing abnormalities in liver function tests (LFT) in COVID-19 patients ranging from very mild abnormalities in the non-cirrhotic patients to moderate elevation of liver enzymes in the cirrhotic patients [
1,
2]. Our recent review showed that 14–53% of patients with COVID-19 developed hepatic dysfunction and 2–11% of patients had underlying chronic liver disease [
3]. …